Mixed reality moves into the enterprise mainstream

Tern plc

A new phase of computing is taking shape as artificial intelligence and mixed reality converge. The shift from virtual to spatial computing marks the point where digital content no longer replaces reality but enhances it, and this time the technology is ready to scale.

Over the past ten years, immersive devices have moved through several hype cycles. Oculus, Vive, and Meta each pushed boundaries, but adoption stalled outside specialist sectors. Apple changed that dynamic with the launch of Vision Pro, positioning mixed reality as a serious computing platform rather than an entertainment accessory.

In parallel, AI has embedded itself across business software, creating intelligent systems that learn, predict, and respond to human needs. The merging of these two technologies is transformative. Mixed reality now has access to real-time understanding through AI, allowing devices to see, hear, and act on context. As hardware becomes lighter and socially acceptable, mixed reality glasses are set to evolve into all-day wearables that deliver live guidance, data access, and communication.

Meta’s display glasses with gesture control, Samsung and Google’s Moohan headset with Gemini AI, Amazon’s Jayhawk smart glasses for employees, and Apple’s Vision Air all signal a shared destination. By 2028, these devices will move into everyday enterprise use.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Device Authority highlights security risks as AI begins controlling physical machines

Device Authority examines the security risks of AI-controlled machinery and the role of device identity, authentication and access controls...

Talking Medicines targets better pharmaceutical launch results through message analysis

Talking Medicines' Message Resonance Score measures doctors' understanding of pharmaceutical messaging to help companies improve launch strategies....

Search